BCL2 and leukemia: To explore the underlying mechanisms of the apparent sensitivity of AE-positive leukemia cells to C646, we evaluated post-treatment levels of histone acetylation and expressions of c-kit and bcl-2 in Kasumi-1 and SKNO-1 cell lines, which characterized by harboring c-kit mutation/overexpression, as well as bcl-2 overexpression.